Michael Auld is an experienced professional in the pharmaceutical industry, currently serving as the Director of Strategic Forecasting at Merck since July 2022. Prior to this role, Auld worked at Bristol Myers Squibb as the Associate Director for Multiple Myeloma within the US Hematology Commercial Forecasting team from June 2020 to July 2022. Auld's career began at ZS, where tenure spanned from June 2014 to June 2020, leading to positions as Consultant, Associate Consultant, and Business Analyst. Michael Auld holds a Bachelor's Degree in Mechanical Engineering from Rensselaer Polytechnic Institute.
This person is not in any teams
This person is not in any offices